Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Molecular Diagnostics › Strata Oncology Raises $26M in Series B Financing Round

Strata Oncology Raises $26M in Series B Financing Round

May 23, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Strata Oncology announced today that it has closed a $26 million Series B funding round. 

Existing investors Arboretum Ventures and Baird Capital were joined in the round by new investors Pfizer Ventures, Merck Global Health Innovation Fund, Deerfield Management, and Renaissance Venture Capital Fund.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. President Biden Announces Plan to Expand SARS-CoV-2 Testing, Increase Capacity

  2. Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

  3. Lucira Health Files for $115M IPO

  4. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  5. Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.